esketamine has been researched along with Bipolar Disorder in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 11 (91.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdo, GL; Barbosa, MG; de Oliveira Cerqueira, R; Del Porto, JA; Del Sant, LC; Delfino, RS; Fava, VAR; Grossi, JD; Lacerda, ALT; Lucchese, AC; Magalhães, E; Nakahira, C; Sarin, LM; Steglich, MS; Surjan, J; Tuena, MA | 1 |
| Cubała, WJ; Wilkowska, A | 1 |
| Del Porto, JA; Delfino, RS; Grossi, JD; Lacerda, ALT; Surjan, J | 1 |
| Andriola, I; Barlati, S; Bassetti, R; Bertolino, A; Cavallotto, C; Chiappini, S; Clerici, M; d'Andrea, G; De Fazio, P; De Filippis, S; Dell'Osso, B; di Giannantonio, M; Di Lorenzo, G; Di Mauro, S; Di Nicola, M; Maina, G; Marcatili, M; Martinotti, G; McIntyre, RS; Nicolò, G; Nucifora, D; Pettorruso, M; Rosso, G; Sensi, SL; Vita, A; Zanardi, R | 1 |
| d'Andrea, G; Lorenzo, GD; Mancusi, G; Martinotti, G; McIntyre, RS; Pettorruso, M | 1 |
| Araújo, GAC; Bisol, LW; Gomes de Matos E Souza, F; Gonçalves, MAS; Júnior, EAB; Leite, TRA | 1 |
| De Fazio, P; de Filippis, R | 1 |
| Barbosa, MG; Del-Porto, JA; Delfino, RS; Fava, VAR; Lacerda, ALT; Lucchese, AC; Magalhães, E; Nakahira, C; Sant, LCD; Sarin, LM; Steglich, MS; Surjan, J; Tuena, MA | 1 |
| Carvalho, I; Chen-Li, D; Gill, H; Lee, Y; Lipsitz, O; Lui, LMW; Mansur, RB; McIntyre, RS; Narsi, F; Rodrigues, NB; Rosenblat, JD; Xiong, J | 1 |
| Chen, Q; Wang, X; Xiao, Z; Zhan, Z; Zhang, B | 1 |
| Jesus-Nunes, AP; Lins-Silva, DH; Quarantini, LC; Souza-Marques, B; Vieira, F | 1 |
| Hashimoto, K | 1 |
3 review(s) available for esketamine and Bipolar Disorder
| Article | Year |
|---|---|
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
Topics: Antidepressive Agents; Bipolar Disorder; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Ketamine | 2023 |
The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Humans; Ketamine; Suicidal Ideation | 2021 |
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Topics: Animals; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; History, 20th Century; History, 21st Century; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate | 2019 |
9 other study(ies) available for esketamine and Bipolar Disorder
| Article | Year |
|---|---|
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
Topics: Administration, Intranasal; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Humans; Ketamine | 2022 |
Comment on "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression".
Topics: Bipolar Disorder; Depressive Disorder, Major; Humans; Ketamine; Suicide | 2023 |
Authors' Response to Comment on "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression".
Topics: Bipolar Disorder; Depressive Disorder, Major; Humans; Ketamine; Suicide | 2023 |
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Topics: Antidepressive Agents; Bipolar Disorder; Depression; Depressive Disorder, Treatment-Resistant; Humans; Ketamine | 2023 |
Giovanni Martinotti: Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine and bipolar × unipolar treatment resistant depression.
Topics: Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Humans; Ketamine | 2023 |
Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report.
Topics: Bipolar Disorder; Borderline Personality Disorder; Humans; Nasal Sprays; Substance-Related Disorders | 2023 |
Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression.
Topics: Anhedonia; Antidepressive Agents; Bipolar Disorder; Humans; Ketamine | 2021 |
Comparative efficacy and side-effect profile of ketamine and esketamine in the treatment of unipolar and bipolar depression: protocol for a systematic review and network meta-analysis.
Topics: Bipolar Disorder; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Meta-Analysis as Topic; Network Meta-Analysis; Randomized Controlled Trials as Topic; Review Literature as Topic | 2021 |
Letter to the editor about "comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression".
Topics: Anhedonia; Bipolar Disorder; Depressive Disorder; Humans; Ketamine | 2021 |